Carlyle Group

The Carlyle Group, Inc. engages in multi-product global alternative asset management. It operates through the following segments: Corporate Private Equity, Real Assets, Global Credit, and Investment Solutions. The Corporate Private Equity segment focuses on buyout, and growth capital funds, which pursue a variety of corporate investments of different sizes and growth potentials. The Real Estate segment consists of real estate, infrastructure and energy, and natural resources. The Global Credit segment includes leveraged loans and structured credit, energy mezzanine opportunities, middle market lending, and distressed debt. The Investment Solutions segment provides comprehensive investment opportunities and resources for the investors and clients to build private equity, and real estate portfolios through funds of funds, secondary purchases of existing portfolios, and managed co-investment programs. The company was founded by William E. Conway Jr., Daniel A. D'Aniello and David M. Rubenstein in 1987 and is headquartered in Washington, DC.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Carlyle Group excels in Q4 2022, eyes growth amid challenges

Carlyle Group's Q4 2022 earnings call highlighted strong financial performance, confidence in growth opportunities for 2023, and a focus on fee-related earnings growth. The firm's strategic initiatives include expanding product offerings, doubling business size, and capitalizing on LPs seeking yield in alternative assets. Challenges include potential margin pressure and LP liquidity needs.

Carlyle Group faces market challenges but sees growth opportunities ahead

Carlyle Group's Q1 2023 earnings call highlighted mixed financial results, strong business fundamentals, and strategic initiatives for growth. Despite challenges in the macro environment and fundraising landscape, the company remains optimistic about its long-term potential and ability to navigate market complexities. Executives emphasized the importance of disciplined growth, operational efficiency, and seizing opportunities in private markets.

Carlyle Group reports resilient Q2 performance amidst market challenges

Carlyle Group navigated a challenging macro environment in Q2 2023 with resilience, reporting solid financial performance and strategic focus.
Despite market uncertainties, the company demonstrated strengths in diversified focus areas, strong financial position, and future growth opportunities.
Challenges from inflation, cost of capital, and market fragility persist, but Carlyle remains optimistic, focusing on selective capital deployment and growth initiatives.

Carlyle Group posts robust Q3 earnings, eyes growth opportunities

Carlyle Group delivered strong financial results in Q3 2023, showcasing operational strength and strategic focus on growth areas like private wealth and investment solutions.
While facing market challenges and uncertainties, the company remains optimistic about future opportunities and its ability to exceed fundraising expectations.
Executives emphasized expense management, talent retention, and operational flexibility as key drivers for future value creation and revenue growth.

Carlyle Group achieves record results and targets growth in 2024

Carlyle Group's Q4 2023 Earnings Call highlighted record results, strategic focus on stakeholder alignment, and plans for growth in Global Credit and Insurance segments. The firm aims to balance returning capital to shareholders with investing in growth opportunities.

Carlyle Group posts record Q1 earnings, eyes growth amid challenges

Carlyle Group delivered strong financial performance in Q1 2024, with record FRE and management fees, demonstrating growth momentum and strategic focus areas.
While facing challenges such as rising defaults in European CLOs and stock-based compensation concerns, the company remains confident in meeting financial targets and capitalizing on opportunities.
Analyst inquiries highlighted areas of interest and potential risks, but management's responses underscored a commitment to growth, successful fee collection, and shareholder value.

Carlyle Group reports record-breaking Q2 performance and eyes growth opportunities

Carlyle Group's Q2 2024 earnings call showcased exceptional performance, robust financial metrics, and strategic transactions. Despite market uncertainties, the company remains optimistic about its outlook and growth prospects, supported by strong fundraising and prudent capital allocation strategies.

Carlyle Group reports record earnings and eyes growth in wealth management

Carlyle Group's Q3 2024 performance showcased robust financial results, driven by record fee-related earnings and strong investment activity across regions.
Despite challenges in the M&A and IPO landscape, the company's global wealth management and CLO business stood out as key strengths.
Looking ahead, Carlyle is well-equipped to seize growth opportunities in asset-backed finance, insurance, and a recovering macroeconomic environment to deliver value to shareholders.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

The Carlyle Group, Inc. is a global investment firm. It operates through the following segments: Global Private Equity (GPE), Global Credit (GC), and Global Investment Solutions (GIS). The GPE segment focuses on buyout and growth capital funds, which pursue a variety of corporate investments of different sizes and growth potentials. The GC segment includes funds and vehicles that pursue investment strategies including loans and structured credit, direct lending, opportunistic credit, distressed credit, aircraft financing and servicing, infrastructure debt, insurance solutions, and global capital markets. The GIS segment provides comprehensive investment opportunities and resources for investors and clients to build private equity portfolios through fund of funds, secondary purchases or financings of existing portfolios, and managed co-investment programs. The company was founded by William Elias Conway Jr., Daniel Anthony D'Aniello, and David Mark Rubenstein in 1987 and is headquartered in Washington, DC.

Carlyle Group (CG) is in talks to acquire Baxter's kidney care unit. The companies started exclusive negotiations in late June and an agreement could be announced as soon as this week.

Carlyle Group (CG) Eyes Buyout of Baxter's Kidney Care Unit

ADC Therapeutics

LONDON, July 08, 2024 (GLOBE NEWSWIRE) -- Myricx Bio (‘Myricx'), a UK biotech company focusing on the discovery and development of a completely novel class of payloads for antibody-drug conjugates (ADCs), today announced the closing of its series A financing raising £90m ($114m). The round was co-led by new leading life science investors Novo Holdings and Abingworth. Additional new investors British Patient Capital (a wholly owned commercial subsidiary of British Business Bank plc, the UK government's economic development bank), Cancer Research Horizons and Eli Lilly and Company also participated alongside founding investors Brandon Capital and Sofinnova Partners.

Myricx Bio Announces £90m ($114m) Series A Financing to Advance its Novel NMTi-ADC Therapeutics into Clinical Development

Private equity firm Carlyle Group is in exclusive talks to acquire Baxter International's kidney care spinoff Vantive for more than $4 billion, including debt, a person familiar with the matter told Reuters on Friday.

Carlyle in talks to buy Baxter's kidney care unit, source says

Private-equity firm Carlyle Group CG -0.74%decrease; red down pointing triangle is in exclusive talks to acquire medical-device maker Baxter's kidney-care spinoff Vantive for more $4 billion, including debt.

Carlyle in Advanced Talks to Acquire Baxter's Vantive

Carlyle (CG) is set to benefit from its efforts to grow organically. However, a rise in expenses due to higher compensation-related costs is likely to hinder its bottom-line growth.

Carlyle (CG) Thrives on Organic Growth Amid High Costs

Discover

Carlyle and KKR & Co won an auction for a $10 billion student loan book from Discover Financial , the Financial Times reported on Wednesday, citing people familiar with the matter.

Carlyle, KKR win auction for $10 bln student loan book from Discover Financial, FT reports

Despite no longer being considered a cheap investment, CG stock remains a favorable buy with a price target of $52/share, offering long-term returns and potential upside. Carlyle Group has shown consistent outperformance compared to the overall market, with record fee-related earnings and strong financial results. Recent M&A activities, including the acquisition of Mediterranean assets, indicate potential for growth and expansion into new markets.

An Update On Carlyle Group After Outperformance And M&A

U.S. private equity firm Carlyle Group is pushing ahead with the sale of Italian fashion brand Twinset, asking potential bidders to submit non-binding offers, two sources close to the matter said on Friday.

Carlyle pushing ahead with sale of Italian fashion brand Twinset, sources say

Energean has agreed to sell its assets in Egypt, Italy and Croatia to private equity fund Carlyle for up to $945 million, the Mediterranean-focused oil and gas producer said on Thursday.

Energean to sell Egypt, other assets to Carlyle for up to $945 mln

Private equity firms Carlyle Group Inc and KKR are among the final bidders for a $10 billion U.S. student loan portfolio from Discover Financial , the Financial Times reported on Thursday.

Carlyle, KKR competing for Discover's $10 bln US student loan portfolio, FT reports

MCLEAN, Va., June 18, 2024 (GLOBE NEWSWIRE) -- Acentra Health, a technology solutions and clinical services company dedicated to helping government healthcare agencies accelerate better health outcomes, today announced that Heather Adamson has joined the company as Senior Vice President of Marketing. In this role, Adamson will oversee the development and implementation of the company's marketing strategy, creating data-driven frameworks to support the company's brand, content, digital, and product marketing programs. She reports to Acentra Health's Chief Growth Officer.

Acentra Health Names Heather Adamson as Senior Vice President of Marketing

PE firm Carlyle has hired advisers to explore a sale of Cogentrix that could value the North Carolina-based power producer at as much as $3 billion to $4 billion, the Financial Times reported, citing three people briefed on the matter.

Carlyle explores sale of electric power producer Cogentrix, FT reports

thyssenkrupp AG

Private equity firm Carlyle and German development bank KfW are in talks to jointly buy most of Thyssenkrupp's submarine unit, three people familiar with the matter said, in the latest sign of how the Ukraine war is reshaping Europe's defence sector.

Focus: Carlyle, KfW join forces in effort to buy Thyssenkrupp warship division, sources say

MCLEAN, Va., June 13, 2024 (GLOBE NEWSWIRE) -- Acentra Health, a technology solutions and clinical services company dedicated to helping government healthcare agencies accelerate better health outcomes, today announced it was awarded a contract from the Oregon Health Authority (OHA) to implement a division of the state's 1115 Health Related Social Needs (HRSN) waiver demonstration for its Medicaid fee-for-service (FFS) members.

Oregon Health Authority Selects Acentra Health to Implement Division of the State's Health-Related Social Needs Benefits for 1115 Medicaid Waiver Demonstration

Carlyle Credit Income Fund is a fixed-income CEF focused on CLO equity, with preferred shares offering an 8.75% coupon rate. The preferred shares are trading above par, with a current yield of 8.47%, but have low liquidity and no upside potential. CCIF is a small fund with leverage, making it susceptible to significant 'gap-down' moves in case of a risk-off event, despite its strong asset manager.

CCIA: Term Preferred Equity From A Carlyle CEF, 8.4% Yield

NEW YORK--(BUSINESS WIRE)--CIBC Innovation Banking is pleased to announce that it recently acted as the lead arranger and an administrative agent on a debt facility for New York-based Yipit, LLC (YipitData), the trusted source of alternative data insights for investment funds and large corporations. YipitData's platform analyzes billions of data points every day to provide accurate, detailed insights and reports on over 2,000 companies providing mission-critical data for investment funds and la.

CIBC Innovation Banking Leads Senior Syndicated Debt Commitment for Yipit, LLC

MCLEAN, Va., June 11, 2024 (GLOBE NEWSWIRE) -- Acentra Health, a technology solutions and clinical services company dedicated to helping government healthcare agencies accelerate better health outcomes, is the winner of the Association of Corporate Growth (ACG) National Capital chapter's Corporate Growth Award for companies over $250 million in annual revenue.

Acentra Health Named ‘Corporate Growth Company of the Year' by ACG National Capital

Private equity firm Carlyle is planning to launch after the summer a sale process for Forgital, an Italian manufacturer of forged components mainly for the aerospace sector, two sources close to the matter said on Friday.

Carlyle to launch sale process for Italy's Forgital after summer - sources

Private equity firm Carlyle is selling a 1.6% stake in Brazilian hospital chain Rede D'Or in a block trade worth about 1.1 billion reais ($213.29 million), local outlets Brazil Journal and Valor Economico reported on Wednesday.

Carlyle sells $213 million in shares of Brazil's Rede D'Or -reports

Alerian MLP ETF

Apollo Global Management

Ares Capital

Ares Management

Brookfield Asset Management

Brookfield Renewable Partners

VanEck Vectors BDC Income ETF

Blackrock Inc

Brookfield Corp

Blackstone Group

Blackstone Secured Lending Fund

TCG BDC

Global X SuperDividend US ETF

Enbridge

Enterprise Products Partners

Energy Transfer LP Unit

FS KKR Capital Corp

Goldman Sachs

Goldman Sachs BDC

JPMorgan Chase & Co

SPDR S&P Regional Banking ETF

Microsoft

High-yield stocks have underperformed recently. We discuss why. We also discuss how we have managed to outperform despite the headwinds and how we plan to continue doing so moving forward.

Very Bad News For Big Dividend Stocks

Carlyle (CG) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.

After Plunging -13.6% in 4 Weeks, Here's Why the Trend Might Reverse for Carlyle (CG)

Carlyle's (CG) first-quarter results benefit from a rise in segment fee revenues, AUM balance and realized performance revenues. However, elevated costs are near-term concerns.

Carlyle (CG) Q1 Earnings Beat Estimates, Stock Falls 8.6%

The headline numbers for Carlyle (CG) give insight into how the company performed in the quarter ended March 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Compared to Estimates, Carlyle (CG) Q1 Earnings: A Look at Key Metrics

The Carlyle Group Inc. (NASDAQ:CG ) Q1 2024 Results Conference Call May 1, 2024 8:30 AM ET Company Participants Daniel Harris - Head of IR Harvey Schwartz - CEO John Redett - CFO Conference Call Participants Brian Bedell - Deutsche Bank Kenneth Worthington - JPMorgan Securities Ben Budish - Barclays Alexander Blostein - Goldman Sachs Brian Mckenna - Citizens JMP Brennan Hawken - UBS Daniel Fannon - Jefferies Chris Kotowski - Oppenheimer Patrick Davitt - Autonomous Research Steven Chubak - Wolfe Research Glenn Schorr - Evercore ISI Bill Katz - TD Cowen Michael Cyprys - Morgan Stanley Craig Siegenthaler - Bank of America Brennan Hawken - UBS Operator Good day, and thank you for standing by. Welcome to The Carlyle Group's First Quarter 2024 Earnings Conference Call.

The Carlyle Group Inc. (CG) Q1 2024 Earnings Call Transcript

Carlyle Credit Income Fund

NEW YORK , April 30, 2024 /PRNewswire/ -- Carlyle Credit Income Fund ("we," "us," "our," "CCIF" or the "Fund") (NYSE: CCIF) announced today that it will release financial results after market close on Wednesday May 29, 2024, for its second quarter of 2024. CCIF will host a conference call at 10:00 a.m.

News for Carlyle Group Stock (CG)